Dr. Jane C. Tan, MD

Dr. Tan practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Tan's NPI, 1124160155, was assigned on February 13, 2007. Dr. Tan graduated from University of Rochester Medical Center in 1995. Dr. Tan holds California license G85943.

Dr. Tan's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Tan's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Tan is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Tan to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Tan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tan practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Tan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Tan is board certified in nephrology by the American Board of Internal Medicine. Dr. Tan is licensed in California.

Dmand AI lists chronic kidney disease among the conditions Dr. Tan treats.

CMS data shows 249 Medicare services from Dr. Tan across 4 procedure codes in 2024, for 145 Medicare patients. Medicare paid $17,748 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 145 Medicare patients who saw Dr. Tan in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 49% are also on Medicaid. Their average risk score is 5.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tan's median patient age at 53, with 46% women.

In 2024, Dr. Tan wrote 245 Medicare Part D claims for 37 patients. 100% of them were for generic drugs. CMS names the drug for 195 of them, across 6 drugs with 11 or more claims each, at $16,287 in total drug cost. In 2023, CMS named 239 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Tan for performance year 2024, reported as part of a group. Dr. Tan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tan as offering telehealth.

Dmand AI links 68 papers to Dr. Tan, published from 2005 to 2025. 2021 was the busiest year, with 10. The most frequent topics are Kidney Transplantation, Kidney Failure, Chronic and Living Donors. Dr. Tan has published most often in Transplantation. Dr. Tan's most frequent co-authors are Xingxing Shelley Cheng, MD, Glenn Matthew Chertow, MD and Stephan Busque, MD.

Dmand AI links Dr. Tan to 2 clinical trials. Conditions studied include Diabetic Nephropathies, Kidney Diseases and Diabetes Complications. Stanford University sponsors the most, 2.

CMS Open Payments shows 4 general payments to Dr. Tan from 4 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 92% of the total. Vertex Pharmaceuticals Incorporated paid the most, $2,860.

Dmand AI lists 1 award for Dr. Tan, most recently CMS Stage 1 EHR in 2013.

Dr. Tan graduated from University of Rochester Medical Center in 1995.

Dr. Tan is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.